Scientists reach holy grail in label-free cancer marker detection: Single molecules

Jul 24, 2013
NYU-Poly nano scientists reach holy grail in label-free cancer marker detection: Single molecules
Researchers illustrate the novel way they detected the BSA protein found in blood -- even smaller than a single cancer marker. As the BSA protein lands on the gold nanoshell that is attached to a microcavity, the bumpy gold sphere acts as a nano-amplifier of the interaction, leading to an enhanced shift in the cavity's resonance frequency. The charted waves show how the light wavelength shifts (red) once the BSA molecule lands on the nanoshell. Credit: NYU-Poly

Just months after setting a record for detecting the smallest single virus in solution, researchers at the Polytechnic Institute of New York University (NYU-Poly) have announced a new breakthrough: They used a nano-enhanced version of their patented microcavity biosensor to detect a single cancer marker protein, which is one-sixth the size of the smallest virus, and even smaller molecules below the mass of all known markers. This achievement shatters the previous record, setting a new benchmark for the most sensitive limit of detection, and may significantly advance early disease diagnostics. Unlike current technology, which attaches a fluorescent molecule, or label, to the antigen to allow it to be seen, the new process detects the antigen without an interfering label.

Stephen Arnold, university professor of applied physics and member of the Othmer-Jacobs Department of Chemical and Biomolecular Engineering, published details of the achievement in Nano Letters, a publication of the American Chemical Society.

In 2012, Arnold and his team were able to detect in solution the smallest known RNA virus, MS2, with a mass of 6 attograms. Now, with experimental work by postdoctoral fellow Venkata Dantham and former student David Keng, two proteins have been detected: a marker protein called Thyroglobulin, with a mass of just 1 attogram, and the bovine form of a common , , with a far smaller mass of 0.11 attogram. "An attogram is a millionth of a millionth of a millionth of a gram," said Arnold, "and we believe that our new limit of detection may be smaller than 0.01 attogram."

This latest milestone builds on a technique pioneered by Arnold and collaborators from NYU-Poly and Fordham University. In 2012, the researchers set the first sizing record by treating a novel with plasmonic gold nano-receptors, enhancing the electric field of the sensor and allowing even the smallest shifts in resonant frequency to be detected. Their plan was to design a medical diagnostic device capable of identifying a single virus particle in a point-of-care setting, without the use of special assay preparations.

At the time, the notion of detecting a single protein—phenomenally smaller than a virus—was set forth as the ultimate goal.

"Proteins run the body," explained Arnold. "When the immune system encounters virus, it pumps out huge quantities of antibody proteins, and all cancers generate protein markers. A test capable of detecting a single protein would be the most sensitive diagnostic test imaginable."

To the surprise of the researchers, examination of their nanoreceptor under a transmission electron microscope revealed that its gold shell surface was covered with random bumps roughly the size of a protein. Computer mapping and simulations created by Stephen Holler, once Arnold's student and now assistant professor of physics at Fordham University, showed that these irregularities generate their own highly reactive local sensitivity field extending out several nanometers, amplifying the capabilities of the sensor far beyond original predictions. "A virus is far too large to be aided in detection by this field," Arnold said. "Proteins are just a few nanometers across—exactly the right size to register in this space."

The implications of single protein detection are significant and may lay the foundation for improved medical therapeutics. Among other advances, Arnold and his colleagues posit that the ability to follow a signal in real time—to actually witness the detection of a single disease and track its movement—may yield new understanding of how proteins attach to antibodies.

Arnold named the novel method of label-free detection "whispering gallery-mode biosensing" because light waves in the system reminded him of the way that voices bounce around the whispering gallery under the dome of St. Paul's Cathedral in London. A laser sends light through a glass fiber to a detector. When a microsphere is placed against the fiber, certain wavelengths of light detour into the sphere and bounce around inside, creating a dip in the light that the detector receives. When a molecule like a clings to a gold nanoshell attached to the microsphere, the microsphere's resonant frequency shifts by a measureable amount.

Explore further: Gelatin nanoparticles could deliver drugs to the brain

More information: pubs.acs.org/doi/abs/10.1021/nl401633y

Related Stories

New microsphere-based methods for detecting HIV antibodies

May 23, 2013

Detection of HIV antibodies is used to diagnose HIV infection and monitor trials of experimental HIV/AIDS vaccines. New, more sensitive detection systems being developed use microspheres to capture HIV antibodies ...

Researchers strike gold with nanotech vaccine

Jun 25, 2013

Scientists in the US have developed a novel vaccination method that uses tiny gold particles to mimic a virus and carry specific proteins to the body's specialist immune cells.

Recommended for you

'Mind the gap' between atomically thin materials

Dec 24, 2014

When it comes to engineering single-layer atomic structures, "minding the gap" will help researchers create artificial electronic materials one atomic layer at a time, according to a team of materials scientists. ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.